148 related articles for article (PubMed ID: 7921003)
21. Physiological role of somatostatin on growth hormone regulation in humans.
Thorner MO; Vance ML; Hartman ML; Holl RW; Evans WS; Veldhuis JD; Van Cauter E; Copinschi G; Bowers CY
Metabolism; 1990 Sep; 39(9 Suppl 2):40-2. PubMed ID: 1976218
[TBL] [Abstract][Full Text] [Related]
22. Quantitative in-situ hybridization histochemistry studies on growth hormone (GH) gene expression in acromegalic somatotrophs: effects of somatostatin, GH-releasing factor and cortisol.
Levy A; Lightman SL
J Mol Endocrinol; 1988 Jul; 1(1):19-26. PubMed ID: 2908268
[TBL] [Abstract][Full Text] [Related]
23. Growth hormone--physiological roles of endogenous GRF and somatostatin in its regulation.
Chihara K
Jpn J Med; 1989; 28(6):788-9. PubMed ID: 2576760
[No Abstract] [Full Text] [Related]
24. Hypothalamic growth hormone-releasing factor (GRF) participates in the negative feedback regulation of growth hormone secretion.
Miki N; Ono M; Miyoshi H; Tsushima T; Shizume K
Life Sci; 1989; 44(7):469-76. PubMed ID: 2564618
[TBL] [Abstract][Full Text] [Related]
25. Pulsatile growth hormone secretion in normal man during a continuous 24-hour infusion of human growth hormone releasing factor (1-40). Evidence for intermittent somatostatin secretion.
Vance ML; Kaiser DL; Evans WS; Furlanetto R; Vale W; Rivier J; Thorner MO
J Clin Invest; 1985 May; 75(5):1584-90. PubMed ID: 2860126
[TBL] [Abstract][Full Text] [Related]
26. Lack of involvement of the cholinergic mechanism in vasoactive intestinal peptide- and peptide-histidine methionine-induced growth hormone (GH) responses in acromegaly: comparison with the GH responses to thyrotropin-releasing hormone and GH-releasing hormone.
Watanobe H; Habu S; Nasushita R; Takebe K
Neuropeptides; 1994 Aug; 27(2):85-90. PubMed ID: 7991070
[TBL] [Abstract][Full Text] [Related]
27. Pattern-dependent suppression of growth hormone (GH) pulsatility by ghrelin and GH-releasing peptide-6 in moderately GH-deficient rats.
Thompson NM; Davies JS; Mode A; Houston PA; Wells T
Endocrinology; 2003 Nov; 144(11):4859-67. PubMed ID: 12960077
[TBL] [Abstract][Full Text] [Related]
28. [Secretion dynamics of GH in 43 patients with acromegaly].
Liuzzi A; Chiodini PG; Botalla L; Cattabeni A; Tosi M; Cremascoli G
Folia Endocrinol; 1972 Oct; 25(5):393-400. PubMed ID: 4679241
[No Abstract] [Full Text] [Related]
29. Growth hormone responses to hp GRF 1-44 amide, bromocriptine and stress in acromegaly are correlated.
Belchetz PE
Postgrad Med J; 1987 Apr; 63(738):241-4. PubMed ID: 3120167
[TBL] [Abstract][Full Text] [Related]
30. Cysteamine-induced enhancement of growth hormone-releasing factor (GRF) immunoreactivity in arcuate neurons: morphological evidence for putative somatostatin/GRF interactions within hypothalamus.
Tannenbaum GS; McCarthy GF; Zeitler P; Beaudet A
Endocrinology; 1990 Nov; 127(5):2551-60. PubMed ID: 1977581
[TBL] [Abstract][Full Text] [Related]
31. Growth hormone releasing factor-test in acromegaly: comparison with other dynamic tests.
Losa M; Schopohl J; Stalla GK; Müller OA; von Werder K
Clin Endocrinol (Oxf); 1985 Aug; 23(2):99-109. PubMed ID: 3931944
[TBL] [Abstract][Full Text] [Related]
32. [Response of growth hormone to the acute test using GH-releasing factor 1-29 in acromegaly. Comparison in the baseline situation and under treatment with prolonged-action somatostatin].
Gavilán I; Santos C; García-Luna PP; Acosta D; Leal-Cerro A; Navarro E; Fernández-López I; Astorga R
Rev Clin Esp; 1988 Mar; 182(4):187-91. PubMed ID: 2901136
[No Abstract] [Full Text] [Related]
33. Neuroendocrine control of growth hormone secretion.
Tannenbaum GS
Acta Paediatr Scand Suppl; 1991; 372():5-16. PubMed ID: 1681677
[No Abstract] [Full Text] [Related]
34. Pharmacological options in the treatment of acromegaly.
Ezzat S
Curr Opin Investig Drugs; 2005 Oct; 6(10):1023-7. PubMed ID: 16259223
[TBL] [Abstract][Full Text] [Related]
35. Interrelationship of somatostatin and growth hormone-releasing hormone in the genesis of the rhythmic secretion of growth hormone.
Tannenbaum GS
Acta Paediatr Scand Suppl; 1990; 367():76-80. PubMed ID: 1977277
[No Abstract] [Full Text] [Related]
36. Intrahypothalamic actions of somatostatin and growth hormone releasing factor on growth hormone secretion.
Willoughby JO; Brogan M; Kapoor R
Neuroendocrinology; 1989 Nov; 50(5):592-6. PubMed ID: 2575238
[TBL] [Abstract][Full Text] [Related]
37. Growth hormone releasing hormone.
Grossman A; Savage MO; Besser GM
Clin Endocrinol Metab; 1986 Aug; 15(3):607-27. PubMed ID: 2429796
[TBL] [Abstract][Full Text] [Related]
38. Failure to confirm a growth hormone-releasing activity of corticotropin-releasing hormone in acromegaly: comparison with the effects of other hypothalamic hormones.
Watanobe H; Sasaki S; Takebe K
Acta Endocrinol (Copenh); 1991 Nov; 125(5):487-90. PubMed ID: 1759537
[TBL] [Abstract][Full Text] [Related]
39. Increased growth hormone pulse frequency in acromegaly.
Barkan AL; Stred SE; Reno K; Markovs M; Hopwood NJ; Kelch RP; Beitins IZ
J Clin Endocrinol Metab; 1989 Dec; 69(6):1225-33. PubMed ID: 2511221
[TBL] [Abstract][Full Text] [Related]
40. Effects of theophylline infusion on the growth hormone (GH) and prolactin response to GH-releasing hormone administration in acromegaly.
Losa M; Alba-Lopez J; Schopohl J; Sobiesczcyk S; Chiodini PG; Müller OA; von Werder K
J Endocrinol Invest; 1988 Oct; 11(9):663-7. PubMed ID: 3146595
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
